Slowly progressive retinitis pigmentosa caused by two novel mutations in the MAK gene. (2018)

First Author: Gray JM
Attributed to:  Developing rhodopsin gene therapy to treat dominant retinitis pigmentosa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/13816810.2018.1474369

PubMed Identifier: 29781741

Publication URI: http://europepmc.org/abstract/MED/29781741

Type: Journal Article/Review

Volume: 39

Parent Publication: Ophthalmic genetics

Issue: 4

ISSN: 1381-6810